Plan for £58m Bristol pharma R&D facility approved

Biotech firm Vectura has got the planning thumbs up to build a major R&D facility in Bristol.
The Chippenham-based firm specialises in asthma inhalers and is understood to have Willmott Dixon lined up to build its planned 10,000m² Inhalation Centre of Excellence.
The £58m project will be built at Bristol & Bath Science Park, with Wilmmott Dixon expected to start construction in early 2023.Michael Austwick, chief executive officer at Vectura, said: “We are delighted